322 related articles for article (PubMed ID: 27151884)
61. Parenteral immunization of mice with a genetically inactivated pertussis toxin DNA vaccine induces cell-mediated immunity and protection.
Fry SR; Chen AY; Daggard G; Mukkur TKS
J Med Microbiol; 2008 Jan; 57(Pt 1):28-35. PubMed ID: 18065664
[TBL] [Abstract][Full Text] [Related]
62. Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice.
Zhang X; Goel T; Goodfield LL; Muse SJ; Harvill ET
J Immunol; 2011 Apr; 186(8):4895-904. PubMed ID: 21398615
[TBL] [Abstract][Full Text] [Related]
63. Construction and preliminary immunobiological characterization of a novel, non-reverting, intranasal live attenuated whooping cough vaccine candidate.
Cornford-Nairns R; Daggard G; Mukkur T
J Microbiol Biotechnol; 2012 Jun; 22(6):856-65. PubMed ID: 22573165
[TBL] [Abstract][Full Text] [Related]
64. Shortcomings of pertussis vaccines: why we need a third generation vaccine.
Poolman JT
Expert Rev Vaccines; 2014 Oct; 13(10):1159-62. PubMed ID: 25089373
[TBL] [Abstract][Full Text] [Related]
65. A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy.
da Silva Antunes R; Soldevila F; Pomaznoy M; Babor M; Bennett J; Tian Y; Khalil N; Qian Y; Mandava A; Scheuermann RH; Cortese M; Pulendran B; Petro CD; Gilkes AP; Purcell LA; Sette A; Peters B
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33690224
[TBL] [Abstract][Full Text] [Related]
66. Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination.
Donnelly S; Loscher CE; Lynch MA; Mills KH
Infect Immun; 2001 Jul; 69(7):4217-23. PubMed ID: 11401957
[TBL] [Abstract][Full Text] [Related]
67. Use of a Neonatal-Mouse Model to Characterize Vaccines and Strategies for Overcoming the High Susceptibility and Severity of Pertussis in Early Life.
Martin Aispuro P; Ambrosis N; Zurita ME; Gaillard ME; Bottero D; Hozbor DF
Front Microbiol; 2020; 11():723. PubMed ID: 32362890
[TBL] [Abstract][Full Text] [Related]
68. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
Mills KH; Gerdts V
J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
[TBL] [Abstract][Full Text] [Related]
69. Immune responses to pertussis vaccines and disease.
Edwards KM; Berbers GA
J Infect Dis; 2014 Apr; 209 Suppl 1():S10-5. PubMed ID: 24158958
[TBL] [Abstract][Full Text] [Related]
70. Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.
Valentini D; Ferrara G; Advani R; Hallander HO; Maeurer MJ
BMC Immunol; 2015 Jul; 16():40. PubMed ID: 26129684
[TBL] [Abstract][Full Text] [Related]
71. Pertussis vaccination and whooping cough: and now what?
Guiso N
Expert Rev Vaccines; 2014 Oct; 13(10):1163-5. PubMed ID: 25020131
[TBL] [Abstract][Full Text] [Related]
72. Do we need a new vaccine to control the re-emergence of pertussis?
Mills KH; Ross PJ; Allen AC; Wilk MM
Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
[TBL] [Abstract][Full Text] [Related]
73. Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis.
Garlapati S; Eng NF; Kiros TG; Kindrachuk J; Mutwiri GK; Hancock RE; Halperin SA; Potter AA; Babiuk LA; Gerdts V
Vaccine; 2011 Sep; 29(38):6540-8. PubMed ID: 21771625
[TBL] [Abstract][Full Text] [Related]
74. Impact of maternal whole-cell or acellular pertussis primary immunization on neonatal immune response.
Martin Aispuro P; Bottero D; Zurita ME; Gaillard ME; Hozbor DF
Front Immunol; 2023; 14():1192119. PubMed ID: 37435078
[TBL] [Abstract][Full Text] [Related]
75. Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.
Gracia A; Polewicz M; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
Vaccine; 2011 Feb; 29(8):1595-604. PubMed ID: 21215343
[TBL] [Abstract][Full Text] [Related]
76. Adaptive immune response to whole cell pertussis vaccine reflects vaccine quality: A possible complementation to the Pertussis Serological Potency test.
Hoonakker ME; Verhagen LM; van der Maas L; Metz B; Uittenbogaard JP; van de Waterbeemd B; van Els CA; van Eden W; Hendriksen CF; Sloots A; Han WG
Vaccine; 2016 Aug; 34(37):4429-36. PubMed ID: 27452867
[TBL] [Abstract][Full Text] [Related]
77. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
[TBL] [Abstract][Full Text] [Related]
78. T-cell immune responses to Bordetella pertussis infection and vaccination.
Fedele G; Cassone A; Ausiello CM
Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242279
[TBL] [Abstract][Full Text] [Related]
79. Canonical and Non-canonical Inflammasome Activation by Outer Membrane Vesicles Derived From
Elizagaray ML; Gomes MTR; Guimaraes ES; Rumbo M; Hozbor DF; Oliveira SC; Moreno G
Front Immunol; 2020; 11():1879. PubMed ID: 32973778
[TBL] [Abstract][Full Text] [Related]
80. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
Watanabe M; Nagai M
Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
